Anesth Analg 2007;105:838-847
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000275190.42912.37
ANALGESIA
Pathophysiology of Peripheral Neuropathic Pain: Immune Cells and Molecules
Michael A. Thacker, MSc, Grad Dip Phys* ,
Anna K. Clark, BSc*,
Fabien Marchand, PhD*, and
Stephen B. McMahon, PhD*
From the *Neurorestoration group, Wolfson Centre for Age Related Diseases; Academic Department of Physiotherapy, Kings College London; and London Pain Consortium, London, UK.
Address correspondence and reprint requests to S.B. McMahon, Kings College London, Neurorestoration group, Wolfson Centre for Age Related Diseases, Wolfson Wing, Hodgkin Building, Guys Campus, London, SE1 1UL, UK. Address e-mail to stephen.mcmahon{at}kcl.ac.uk.
Abstract
Damage to the peripheral nervous system often leads to chronic neuropathic pain characterized by spontaneous pain and an exaggerated response to painful and/or innocuous stimuli. This pain condition is extremely debilitating and usually difficult to treat. Although inflammatory and neuropathic pain syndromes are often considered distinct entities, emerging evidence belies this strict dichotomy. Inflammation is a well-characterized phenomenon, which involves a cascade of different immune cell types, such as mast cells, neutrophils, macrophages, and T lymphocytes. In addition, these cells release numerous compounds that contribute to pain. Recent evidence suggests that immune cells play a role in neuropathic pain in the periphery. In this review we identify the different immune cell types that contribute to neuropathic pain in the periphery and release factors that are crucial in this particular condition.
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Reyes-Gibby, M. R. Spitz, S. Yennurajalingam, M. Swartz, J. Gu, X. Wu, E. Bruera, and S. Shete
Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients
Cancer Epidemiol. Biomarkers Prev.,
October 1, 2009;
18(10):
2636 - 2642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kiguchi, T. Maeda, Y. Kobayashi, Y. Fukazawa, and S. Kishioka
Activation of Extracellular Signal-Regulated Kinase in Sciatic Nerve Contributes to Neuropathic Pain After Partial Sciatic Nerve Ligation in Mice
Anesth. Analg.,
October 1, 2009;
109(4):
1305 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. White, P. Feldman, and R. J. Miller
Chemokine Signaling and the Management of Neuropathic Pain
Mol. Interv.,
August 1, 2009;
9(4):
188 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Shin, C. Pancaro, C. F. Wang, and P. Gerner
Low-Dose Systemic Bupivacaine Prevents the Development of Allodynia After Thoracotomy in Rats
Anesth. Analg.,
November 1, 2008;
107(5):
1587 - 1591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Zhang, X. X. Chi, and G. D. Nicol
Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway
J. Physiol.,
July 1, 2008;
586(13):
3113 - 3127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W.J. Bijlsma and F. P.J.G. Lafeber
Glucosamine Sulfate in Osteoarthritis: The Jury Is Still Out
Ann Intern Med,
February 19, 2008;
148(4):
315 - 316.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. White, H. Jung, and R. J. Miller
Chemokines and the pathophysiology of neuropathic pain
PNAS,
December 18, 2007;
104(51):
20151 - 20158.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|